William Doucette

Dr. William Doucette

University of Iowa College of Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Clinical Therapeutics
Verified
Journal Article
Closed access
WDWilliam Doucette
William Doucette
RMRandal P. McDonough
Randal P. McDonough
DKDonald Klepser
Donald Klepser
RMRenee McCarthy
Renee McCarthy

1 December 2005 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
WDWilliam Doucette
William Doucette
JNJustin Nevins
Justin Nevins
RMRandal P. McDonough
Randal P. McDonough

1 May 2006 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
WDWilliam Doucette
William Doucette
DKDavid H. Kreling
David H. Kreling
JSJon C. Schommer
Jon C. Schommer
CGCaroline A. Gaither
Caroline A. Gaither
DMDavid A. Mott
David A. Mott
CPCraig A. Pedersen
Craig A. Pedersen

1 June 2017 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
AAAli Azeez Al-Jumaili
Ali Azeez Al-Jumaili
WDWilliam Doucette
William Doucette

28 April 2009 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
PDF file
WDWilliam Doucette
William Doucette
MWMatthew J Witry
Matthew J Witry
KFKaren B Farris
Karen B Farris
RMRandal P Mcdonough
Randal P Mcdonough
Background: Pharmacists in various settings have been effective in initiating diabetes treatment. Patients with diabetes require ongoing disease management, and community pharmacists are in a strategic position to provide such extended care. Little is known, however, about the effects of community pharmacist–provided interventions beyond the initial treatment period. Objective: To evaluate the effect of community pharmacist–provided extended diabetes care service on primary clinical outcomes, including hemoglobin A 1c (A1C), low-density lipoprotein cholesterol (LDL-C), and blood pressure, and on patients' reported self-care activities. Methods: A randomized controlled trial was conducted in patients with diabetes. Participants had already completed at least 2 diabetes education sessions at a local diabetes education center. Nine specially trained pharmacists administered interventions during up to 4 quarterly visits per patient. Interventions included discussing medications, clinical goals, and self-care activities with patients and recommending medication changes to physicians when appropriate. The main outcome measures were 12-month changes in A1C, LDL-C, blood pressure, and self-report of self-care activities. Results: Seventy-eight patients participated in the study (36 intervention, 42 control); 66 were included in the final analysis (31 intervention, 35 control). Compared with changes in the control group, patients who received interventions significantly increased the number of days per week that they engaged in a set of diet and diabetes self-care activities (1.25 and 0.73 more days/wk, respectively). The mean 12-month changes for A1C, LDL-C, and blood pressure were not significantly different between the 2 study groups. Conclusions: Although pharmacist-provided interventions did not demonstrate statistically significant improvements in clinical outcomes over the study period, study results did show that pharmacists were effective at increasing the number of days that patients spent engaging in healthy diet and diabetes self-care activities. Addressing lifestyle and self-care behaviors can be a beneficial component of a pharmacist-provided extended diabetes care service.

1 July 2012 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
WDWilliam Doucette
William Doucette
JNJustin C. Nevins
Justin C. Nevins
CGCaroline Gaither
Caroline Gaither
DKDavid H. Kreling
David H. Kreling
DMDavid A. Mott
David A. Mott
JSJon C. Schommer
Jon C. Schommer